Open account
Sign up/Log in
MARKET
CCEL
CCEL
Cryo-Cell Intl Inc
AMEX
8.29
-0.02
-0.24%
Closed 15:36 05/01 EDT
OPEN
8.23
PREV CLOSE
8.31
HIGH
8.55
LOW
8.01
VOLUME
9.39K
TURNOVER
0
52 WEEK HIGH
8.67
52 WEEK LOW
3.670
MARKET CAP
67.19M
P/E (TTM)
-7.0529
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at CCEL last week (0422-0426)?
Weekly Report · 2d ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Tevogen Bio Holdings (NASDAQ:TVGN) shares rose 75.3% to $1.49 during Friday's pre-market session. Cryo-Cell International (AMEX:CCEL) shares increased by 27.94% during the session. Fresh2 Group shares moved upwards by 18.33%.
Benzinga · 5d ago
Weekly Report: what happened at CCEL last week (0415-0419)?
Weekly Report · 04/22 09:56
CRYO-CELL International GAAP EPS of $0.07 beats by $0.13, revenue of $7.85M misses by $0.1M
Earnings News CRYO-CELL International GAAP EPS of $0.07 beats by $ 0.13, revenue of $7.85M misses by $0.-1M. ETCryo-Cell International, Inc. (CCEL) reports Q1 GAAP results.
Seeking Alpha · 04/16 07:36
CCEL Stock Earnings: Cryo-Cell International Beats EPS, Misses Revenue for Q1 2024
Cryo-Cell International reported earnings per share of 7 cents for the first quarter of 2024. The company reported revenue of $7.85 million. This was 1.01% worse than the analyst estimate for revenue in the same period. Cryo-cell International reported results for the quarter.
Investorplace · 04/16 02:52
Cryo-Cell International, Inc. Quarterly Report on Form 10-Q
Press release · 04/15 23:03
Cryo-Cell International Q1 EPS $0.07 Beats $(0.02) Estimate, Sales $7.85M Miss $7.93M Estimate
Cryo-Cell International (NASDAQ:CCEL) reported quarterly earnings of $0.07 per share. The company reported quarterly sales of $7.85 million which missed the analyst consensus estimate by 1.01%. The company's sales for the quarter were up 0.38 percent from the same period last year.
Benzinga · 04/15 21:05
*Cryo-Cell International 1Q EPS 7c >CCEL
Dow Jones · 04/15 21:01
About CCEL
Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 235,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
Webull offers CRYO-CELL International, Inc. stock information, including AMEX: CCEL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CCEL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.
You can practice and explore trading CCEL stock methods without spending real money on the virtual paper trading platform.